According to Crunchbase, Dr. Cameron Clokie is a maxillofacial and oral surgeon, entrepreneur and scientist. Currently he is the CEO of Induce Biologics which is a company that focuses on solutions for musculoskeletal reconstruction through regenerative medicine.
In 1998, Clokie was named Professor of Oral and Maxillofacial Surgery and Head of Oral and Maxillofacial Surgery at the University of Canada in Toronto. Cameron has published several papers and performed several presentations both internationally and nationally.
His research focuses on regenerative and reconstructive medicine. Dr. Clokie has successfully developed allies with companies in the industry that have helped him to create new businesses. Learn more about Cameron Clokie: https://ca.linkedin.com/in/dr-cameron-clokie-136991109https://ca.linkedin.com/in/dr-cameron-clokie-136991109
Regenerative medicine has show potential in managing strokes, heart disease and cardiac arrest. The process is to use stem cells to promote healing in an efficient manner. Studies have supported Dr. Clokie’s theory that stem cells help manage nervous system and cardiac diseases.
When used carefully, stem cells can help prevent heart attacks by regenerating damaged heart tissues. Stem cells can be used to treat other health problems as well. They can take the form of any cell and become white blood cells to fight viral problems. Hundreds of thousands of lives can be saved with continued stem cell research and the expertise of Dr. Cameron Clokie.
Hopefully in the future, we will no longer need to use artificial hearts. Artificial hearts are often rejected by the body. Regenerative medicine uses cells from your own body. This means your body will accept it and replace a damaged heart with a healthy one.
Experts in the health industry are constantly reiterating that stem cell procedures could help give our economy a much needed boost. A study has shown that regenerative health and stem cell research could bring in $18 billion. By the year 2021 it has the capability to increase to a whopping $53 billion.